The ANKRD11 gene helps control how other genes are switched on during early growth, especially in the brain, bones, and face. This gene plays an important role in development, so a harmful variant can cause KBG syndrome, which may involve delayed development, learning or speech differences, short stature, and distinct teeth or facial features. Some people also have hearing loss, seizures, or behavior differences. Many variants in this gene have little effect, while a clearly harmful variant can help confirm the diagnosis.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells can use to make molecules or regulate processes in the body. Some genes provide the directions for building proteins, which are the parts of cells that do much of the work. Other genes mainly help determine when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To explore this topic in more detail, you can find more in the LearnHub.
Overview
ANKRD11Gene function
What if the gene works
The ANKRD11 gene helps control how other genes are turned on and off. It supports normal growth and development, especially in the brain, bones, and face.
Risk
What if the gene does not work
Variants in the ANKRD11 gene most often cause KBG syndrome, which can affect learning, behavior, growth, teeth, and bone development. Milder and more severe variants can influence which features appear and how early or noticeable they are.
Treatment
What does that mean for your treatment
No treatment or drug choice specific to a pathogenic variant in the ANKRD11 gene is currently established. Care is guided by each person’s symptoms and needs, and the ANKRD11 gene is mainly being studied in early research rather than used to direct routine medicines.
Conditions associated with ANKRD11
Gene function
What if the gene works
Cells need a clear schedule for which instructions to use and when. The ANKRD11 gene helps set that schedule, so growth and development can unfold in an organized way. This helps explain how the ANKRD11 gene helps control other genes across the body.
The ANKRD11 gene helps cells turn many other genes on or off at the right time. This keeps important body instructions coordinated as cells grow, divide, and mature.
Its protein works with other proteins that loosen or tighten DNA packaging in the nucleus. That helps cells reach the instructions they need while keeping other instructions quieter.
ANKRD11 acts like a meeting point for several proteins involved in gene control. By bringing these helpers together, it supports smooth day to day cell activity and normal development.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help explain normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply reflect natural genetic variation. Sometimes, however, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many disease-causing variants in the ANKRD11 gene make the protein too short or unstable, so cells end up with much less working ANKRD11 protein. Other variants can alter key parts of the protein and only partly weaken how it helps control the activity of other genes, which explains how ANKRD11 gene variants affect protein function. Milder variants may leave some activity, while more severe variants often cause a greater loss of function and can be linked to earlier or more noticeable features of KBG syndrome.
How variants are linked to conditions
Pathogenic variants in the ANKRD11 gene are a well established cause of KBG syndrome. In the ANKRD11 gene KBG syndrome link, the genetic finding can confirm the diagnosis rather than simply suggest a higher risk. People with this condition often have developmental delay or learning difficulties, short stature, hearing loss, seizures, and characteristic facial or dental features.
A variant is not necessarily a diagnosis
Variants in genes are a usual part of human biology and are widespread in the general population. Most of these variants do not directly affect health and simply contribute to normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ANKRD11, risk is mainly tied to whether a disease-causing change in the gene is present, either inherited from a parent or happening for the first time in a child. There is not enough evidence to say that diet, exercise, or other lifestyle changes lower the chance of having the related condition.
Inheritance of ANKRD11 variants
ANKRD11-related KBG syndrome follows an autosomal dominant inheritance pattern, which means one altered copy of the ANKRD11 gene can be enough to cause the condition. If a parent carries a disease-causing variant, each child has a 50% chance of inheriting it. This is the key point in understanding how ANKRD11 variants are inherited in families. Some people have a new, de novo variant in the ANKRD11 gene, meaning it started in them and was not inherited from either parent.
What does my ANKRD11 result mean for my family?
For ANKRD11, a disease-causing result is usually linked to a dominant condition called KBG syndrome, so close relatives such as parents, siblings, and children may also carry the same change. Each child of an affected parent has a 1 in 2, or 50%, chance of inheriting it. Some ANKRD11 changes happen for the first time in one person, so a parent may not have the variant.
Genetic information
Genetic testing
How you find out about variants
Variants in the ANKRD11 gene are usually found through ANKRD11 genetic testing, which analyzes DNA from a blood or saliva sample. It may be checked as part of a gene panel or a broader exome test, and results can show whether a variant helps explain a person’s features or confirms a diagnosis.
When should I consider getting a genetic test?
Consider ANKRD11 testing when a child or adult has features linked with KBG syndrome, such as developmental delay, learning problems, short stature, seizures, hearing loss, or unusually large upper front teeth. Testing can also help when these features run in the family or when a doctor suspects this condition.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, yet how much it explains varies based on the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, affect how the body functions. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, these results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small inherited differences can change how quickly a drug is broken down, how strongly it acts, or how likely side effects are. This helps explain why the same treatment works well for one person but less well for another. These differences are common and can influence both benefit and sensitivity to treatment.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medications. By looking at relationships between genes and drugs, it helps explain why treatments may work differently from one person to another. For many medicines, genes can influence how strong a drug’s effects are or how the body processes it. This information can help support treatment decisions that are more informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the ANKRD11 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so general concerns about side effects, new symptoms, or how a treatment is affecting you are best discussed with your doctor.
History
KBG syndrome was first described in the 1970s, years before its genetic cause was known. In 2011, researchers linked many cases to variants in the ANKRD11 gene, giving families a clearer explanation for a pattern of features that had long been recognized clinically. The name KBG came from the initials of the first families reported with the condition, which reflects how early medicine often identified syndromes by observation before genes were found. Building on this early work, scientists uncovered more about the ANKRD11 gene through broader DNA testing in children and adults with similar features. This helped expand the known range of the condition, including milder presentations. Over time, descriptions became more precise as genetic testing connected scattered clinical reports into one clearer diagnosis.